Medical-necessity and step-therapy denials are appealable with documentation
A patient on "the best" GLP-1 medication (by name) who titrates too quickly, skips doses, or stops at the first side effect will have worse outcomes than a patient on "the worst" GLP-1 medication who titrates slowly, stays consistent, and reaches maintenance dose
Tissue processing and quantification of cFOS was conducted as previously described 37
Consult your GP or diabetes specialist nurse before making changes to ensure this suits your specific medication and circumstances
02 Storage guidance Refrigerate the supplied material, freeze for long-term storage, and protect it from heat, moisture, and direct light
Be sure to keep the patch out of reach of children and consult with a healthcare professional before using any new products